Updated:
Deutsche Apotheker- und Ärztebank
Deutsche Apotheker- und Ärztebank, universally known as apoBank, was established in 1902 as a credit cooperative for pharmacists. It later expanded its mandate...
Deutsche Apotheker- und Ärztebank
Deutsche Apotheker- und Ärztebank, universally known as apoBank, was established in 1902 as a credit cooperative for pharmacists. It later expanded its mandate to include physicians and dentists, creating a mutual structure owned by its professional members. The bank's founding purpose — providing financial services to independent healthcare practitioners — remains its core identity, making it both a retail bank and a specialized lender with a membership base concentrated in high-earning, recession-resilient professions. The bank operates across three main asset silos. The largest is its direct lending book: loans to finance medical practice acquisitions, equipment purchases, and practice real estate. This is complemented by a substantial portfolio of commercial real estate, much of it medical office buildings and healthcare facilities. In September 2023, apoBank participated in a consortium providing €150 million in debt financing to a German medical center operator. Its third silo is a securities portfolio that includes senior secured private credit positions in healthcare infrastructure, though specific holdings are not publicly disclosed. Geographically, the bank focuses almost entirely on Germany, with a minor footprint in Austria. apoBank reports a balance sheet total north of €50 billion, making it one of the twenty largest banks in Germany by that measure. It maintains branch offices in major university-hospital cities including Berlin, Munich, and Hamburg. The bank's cooperative structure means it has no external shareholders; profits are retained or distributed as dividends to member-owners. As of May 2024, apoBank announced a strategic partnership with a German fintech to digitize practice-financing applications, signaling modernization of its core credit workflow. The bank's structural differentiator is its monoline focus on a single demographic — accredited healthcare professionals — within a mutual governance model. This design produces extremely low default rates on its practice loans and creates a deposit base sticky enough to fund illiquid healthcare real estate and private credit allocations without the asset-liability mismatches that constrain commercial banks with more flighty depositors.
General information
Firm type
Bank / Wealth / Trust
Year founded
1902
Location
Region
Europe
Country
Germany
City
Düsseldorf
Corporate office
Düsseldorf, Germany
Principals
Matthias Schellenberg
Chairman of the Board of Directors
Sector focus
Frequently asked questions
Who runs investment decisions at Deutsche Apotheker- und Ärztebank?
The chairman of the board of directors, Matthias Schellenberg, sets the strategic direction, while the bank's treasury and credit committees execute investment and lending decisions within board-approved risk parameters. The mutual ownership structure means no external asset manager controls allocations; the board is elected by the cooperative's healthcare-professional members.
What asset classes does apoBank deploy capital into?
The bank originates loans to healthcare practitioners for practice acquisitions and equipment, holds a portfolio of medical office and healthcare-related commercial real estate, and maintains a securities book that includes private credit positions in healthcare infrastructure. It does not operate as a venture investor or take equity stakes in operating companies outside its lending relationships.
How is apoBank structured — is it a family office or a retail bank?
It is neither. apoBank is a cooperative bank owned by its member-account holders — roughly 475,000 pharmacists, physicians, and dentists — rather than by external shareholders or a single family. This gives it a governance model closer to a credit union, with profits distributed as dividends to members or reinvested in the institution.
Does apoBank invest outside Germany?
Its lending and real estate exposure is overwhelmingly domestic, concentrated in German medical hubs. The bank maintains a minor cross-border presence in Austria, but is not a pan-European allocator. Its private credit securities portfolio may include exposures to European healthcare infrastructure, though specific non-German holdings are not publicly itemized.
How is the bank's credit risk profile different from a commercial bank?
The member base — licensed physicians, dentists, and pharmacists — represents a demographic with historically low default rates and income streams insulated from broad economic cycles. This enables the bank to extend longer-duration loans against practice cash flows without the consumer or SME credit risk that shapes most commercial bank balance sheets.
Does apoBank manage philanthropic structures?
The bank operates a foundation, the apoBank-Stiftung, which awards grants and scholarships to healthcare students and supports medical research. The foundation is legally separate from the bank's lending and investment balance sheet, though it benefits from the bank's annual charitable contributions.
What is the bank's relationship to the German cooperative banking network?
apoBank is a member of the Bundesverband der Deutschen Volksbanken und Raiffeisenbanken, the national association of cooperative banks. However, it operates independently with its own specialized mandate — it is not part of a regional Volksbank, and its healthcare focus distinguishes it from all other cooperative institutions in Germany.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: